DaVita Inc. (NYSE:DVA) Shares Bought by Nordea Investment Management AB

Nordea Investment Management AB lifted its holdings in shares of DaVita Inc. (NYSE:DVA) by 4.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 264,535 shares of the company’s stock after purchasing an additional 12,339 shares during the quarter. Nordea Investment Management AB’s holdings in DaVita were worth $39,712,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in DVA. Transcendent Capital Group LLC acquired a new stake in DaVita in the 3rd quarter worth about $25,000. Blue Trust Inc. boosted its position in shares of DaVita by 56.4% in the third quarter. Blue Trust Inc. now owns 330 shares of the company’s stock worth $54,000 after acquiring an additional 119 shares during the last quarter. Quarry LP purchased a new stake in DaVita in the third quarter valued at approximately $60,000. Point72 Hong Kong Ltd acquired a new position in DaVita during the second quarter worth approximately $68,000. Finally, Versant Capital Management Inc raised its stake in DaVita by 58.7% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $68,000 after purchasing an additional 169 shares during the period. Hedge funds and other institutional investors own 90.12% of the company’s stock.

DaVita Trading Up 0.8 %

Shares of DVA opened at $152.73 on Wednesday. DaVita Inc. has a 12 month low of $103.40 and a 12 month high of $169.51. The stock’s 50-day moving average is $154.88 and its two-hundred day moving average is $151.87. The company has a debt-to-equity ratio of 15.78, a current ratio of 1.37 and a quick ratio of 1.33. The stock has a market cap of $12.52 billion, a PE ratio of 16.48, a P/E/G ratio of 0.86 and a beta of 0.92.

DaVita (NYSE:DVA) last released its quarterly earnings results on Tuesday, October 29th. The company reported $2.59 earnings per share for the quarter, missing analysts’ consensus estimates of $2.76 by ($0.17). DaVita had a return on equity of 88.18% and a net margin of 6.53%. The company had revenue of $3.26 billion during the quarter, compared to analysts’ expectations of $3.25 billion. During the same quarter in the prior year, the company earned $2.85 EPS. The firm’s revenue was up 4.6% compared to the same quarter last year. Equities analysts forecast that DaVita Inc. will post 9.71 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on DVA. Barclays increased their target price on DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 31st. Truist Financial raised their price objective on DaVita from $165.00 to $175.00 and gave the stock a “hold” rating in a report on Monday, October 7th. One analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the company. According to MarketBeat.com, DaVita presently has a consensus rating of “Hold” and a consensus price target of $161.80.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.